GenoFocus, Inc.

A187420

KR7187420005

Commodity Chemicals

End-of-day quote Korea S.E. Other stock markets 03:30:00 17/05/2024 am IST			5-day change	1st Jan Change
4,025 ^KRW	-1.11%		-2.54%	+3.07%

2023	GenoFocus, Inc. agreed to acquire an additional 13.38% stake in GF Fermentech Co., Ltd. for KRW 5.9 billion	CI
2023	GenoFocus, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI

GenoFocus, Inc.(KOSDAQ:A187420) added to S&P Global BMI Index

September 20, 2021 at 09:30 am IST

Latest news about GenoFocus, Inc.

GenoFocus, Inc. agreed to acquire an additional 13.38% stake in GF Fermentech Co., Ltd. for KRW 5.9 billion	17/23/17	CI
GenoFocus, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/23/15	CI
GenoFocus, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23/23/23	CI
GenoFocus, Inc.(KOSDAQ:A187420) dropped from S&P Global BMI Index	19/22/19	CI
GenoFocus, Inc. announced that it expects to receive KRW 23.2 billion in funding	28/22/28	CI
GenoFocus, Inc.(KOSDAQ:A187420) added to S&P Global BMI Index	20/21/20	CI
GenoFocus, Inc. announced that it has received KRW 10 billion in funding	24/20/24	CI
GenoFocus, Inc. announced that it expects to receive KRW 10 billion in funding	21/20/21	CI
GenoFocus, Inc. to Enter into Co-Development Agreement with Eight Organizations for COVID-19	03/20/03	CI
GenoFocus, Inc.(KOSDAQ:A187420) dropped from S&P Global BMI Index	23/19/23	CI
GenoFocus, Inc. acquired 65.35% stake in Sungwun Bio Co., Ltd. from Sungwun Pharmacopia Co. Ltd. for KRW 5 billion.	10/17/10	CI
Geno Focus, Inc. announced that it has received KRW 30.8 billion in funding from Shinhan Capital, Investment Arm and other investors	01/16/01	CI
Geno Focus, Inc. announced that it expects to receive KRW 30.8 billion in funding from Shinhan Capital, Investment Arm and other investors	27/16/27	CI
Geno Focus, Inc.(KOSDAQ:A187420) added to S&P Global BMI Index	21/15/21	CI
Geno Focus, Inc. has completed an IPO in the amount of KRW 13.20 billion.	22/15/22	CI
Geno Focus, Inc. has filed an IPO.	18/14/18	CI

GenoFocus, Inc. is a Korea-based company principally engaged in the development, manufacture and distribution of enzymes. The Company mainly manufactures catalases, lactase, phytases and other enzymes. The catalases are mainly used for industry, including processing of semiconductors, petroleum and propylene oxide, medical therapeutics, food processing, contact-lens and other industries. The lactases are mainly used for food processing including processing of milk, yogurt and milk serum. The phytases are mainly used for processing of animal feed. And the Company is exploring new businesses, engaged in development of other enzymes including therapeutic enzymes, chemical agents and others.

Sector

Commodity Chemicals

Calendar

13/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Commodity Chemicals

	1st Jan change	Capi.
GENOFOCUS, INC.	+3.07%	67.7M
AIR LIQUIDE	+5.41%	106B
SABIC	-3.11%	64.74B
PT CHANDRA ASRI PACIFIC TBK	+73.33%	49.34B
WANHUA CHEMICAL GROUP CO., LTD.	+17.24%	39.15B
LYONDELLBASELL INDUSTRIES N.V.	+6.13%	32.86B
WESTLAKE CORPORATION	+12.77%	20.29B
NINGXIA BAOFENG ENERGY GROUP CO., LTD.	+15.03%	17.21B
HENGLI PETROCHEMICAL CO.,LTD.	+19.06%	15.28B
RONGSHENG PETROCHEMICAL CO., LTD.	+6.28%	14.58B

Other Commodity Chemicals

GenoFocus, Inc.

Equities

A187420

KR7187420005

Commodity Chemicals

GenoFocus, Inc.(KOSDAQ:A187420) added to S&P Global BMI Index

Latest news about GenoFocus, Inc.

Chart GenoFocus, Inc.

Company Profile

Income Statement Evolution

Sector Other Commodity Chemicals